| The “Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies”(SPRINTT) randomized controlled trial: design and methods F Landi, M Cesari, R Calvani, A Cherubini, M Di Bari, R Bejuit, J Mshid, ... Aging clinical and experimental research 29, 89-100, 2017 | 181 | 2017 |
| The “Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies”(SPRINTT) randomized controlled trial: Case finding, screening and characteristics of … E Marzetti, M Cesari, R Calvani, J Msihid, M Tosato, L Rodriguez-Mañas, ... Experimental gerontology 113, 48-57, 2018 | 86 | 2018 |
| Indirect treatment comparison of biologics in chronic rhinosinusitis with nasal polyps AT Peters, JK Han, P Hellings, E Heffler, P Gevaert, C Bachert, Y Xu, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (6), 2461-2471. e5, 2021 | 67 | 2021 |
| Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps C Hopkins, M Wagenmann, C Bachert, M Desrosiers, JK Han, ... International forum of allergy & rhinology 11 (7), 1087-1101, 2021 | 56 | 2021 |
| Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to … A Boyapati, J Msihid, S Fiore, J van Adelsberg, NMH Graham, ... Arthritis Research & Therapy 18, 1-12, 2016 | 45 | 2016 |
| Identification of sarilumab pharmacodynamic and predictive markers in patients with inadequate response to TNF inhibition: a biomarker substudy of the phase 3 TARGET study C Gabay, J Msihid, M Zilberstein, C Paccard, Y Lin, NMH Graham, ... RMD open 4 (1), e000607, 2018 | 35 | 2018 |
| Association of high serum Interleukin‐6 levels with severe progression of rheumatoid arthritis and increased treatment response differentiating Sarilumab from adalimumab or … A Boyapati, S Schwartzman, J Msihid, E Choy, MC Genovese, ... Arthritis & Rheumatology 72 (9), 1456-1466, 2020 | 34 | 2020 |
| Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes C Gabay, GR Burmester, V Strand, J Msihid, M Zilberstein, T Kimura, ... Arthritis research & therapy 22, 1-11, 2020 | 31 | 2020 |
| High levels of interleukin-6 in patients with rheumatoid arthritis are associated with greater improvements in health-related quality of life for sarilumab compared with adalimumab V Strand, SH Boklage, T Kimura, F Joly, A Boyapati, J Msihid Arthritis research & therapy 22, 1-9, 2020 | 29 | 2020 |
| Lixisenatide resensitizes the insulin‐secretory response to intravenous glucose challenge in people with type 2 diabetes–a study in both people with type 2 diabetes and healthy … RHA Becker, J Stechl, J Msihid, C Kapitza Diabetes, Obesity and Metabolism 16 (9), 793-800, 2014 | 29 | 2014 |
| Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma ED Bateman, AH Khan, Y Xu, P Guyot, J Chao, S Kamat, P Rowe, ... Respiratory Medicine 191, 105991, 2022 | 27 | 2022 |
| Dupilumab improves health related quality of life: results from the phase 3 SINUS studies SE Lee, C Hopkins, J Mullol, J Msihid, I Guillemin, N Amin, LP Mannent, ... Allergy 77 (7), 2211-2221, 2022 | 24 | 2022 |
| Dupilumab in adults with moderate-to-severe atopic dermatitis and prior use of systemic non-steroidal immunosuppressants: analysis of four phase 3 trials C Griffiths, M de Bruin-Weller, M Deleuran, MC Fargnoli, ... Dermatology and Therapy 11 (4), 1357-1372, 2021 | 21 | 2021 |
| Glp-1 agonist for use in the treatment of stenosis or/and obstruction in the biliary tract J Stechl, I Nowotny, C Pfeiffer, JL Pinquier, J Msihid | 21 | 2013 |
| A longitudinal observational study of a cohort of patients with relapsing–remitting multiple sclerosis treated with glatiramer acetate M Debouverie, T Moreau, C Lebrun, O Heinzlef, F Brudon, J Msihid European journal of neurology 14 (11), 1266-1274, 2007 | 19 | 2007 |
| Glp-1 agonist for use in the treatment of stenosis or/and obstruction in the pancreatic duct system J Stechl, I Nowotny, C Pfeiffer, JL Pinquier, J Msihid | 18 | 2013 |
| Cardiovascular impact of exercise and drug therapy in older hypertensives with coronary heart disease: PREHACOR study JJ Mourad, N Danchin, J Puel, H Gallois, J Msihid, ME Safar, H Tanaka Heart and vessels 23, 20-25, 2008 | 10 | 2008 |
| Dupilumab Efficacy in patients with uncontrolled or oral Corticosteroid–Dependent allergic and nonallergic asthma G Brusselle, S Quirce, A Papi, P Kuna, BE Chipps, NA Hanania, M Blaiss, ... The Journal of Allergy and Clinical Immunology: In Practice 11 (3), 873-884. e11, 2023 | 9 | 2023 |
| 069 High baseline serum IL-6 identifies a subgroup of rheumatoid arthritis patients with rapid joint damage and clinical progression and predicts increased sarilumab treatment … A Boyapati, J Msihid, S Schwartzman, E Choy, GR Burmester, G Lam, ... Rheumatology 58 (Supplement_3), kez106. 068, 2019 | 9 | 2019 |
| Improvement in health-related quality of life with dupilumab in patients with moderate-to-severe asthma with comorbid chronic rhinosinusitis with/without nasal polyps: an … C Hopkins, KM Buchheit, E Heffler, NA Cohen, H Olze, AH Khan, J Msihid, ... Journal of Asthma and Allergy, 767-773, 2022 | 7 | 2022 |
